Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry
|
March 14, 2022
De novo Design of SARS-CoV-2 Main Protease Inhibitors
Christian Fischer, Nynke A Vepřek, Zisis Peitsinis, et al.
Cell
|
April 14, 2015
Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion
Oren S Rosenberg, Dustin Dovala, Xueming Li, et al.
Elife
|
June 20, 2022
Comprehensive fitness landscape of SARS-CoV-2 M<sup>pro</sup> reveals insights into viral resistance mechanisms
Julia M Flynn, Neha Samant, Gily Schneider-Nachum, et al.
Viruses
|
March 30, 2023
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses
Sarah N Zvornicanin, Ala M Shaqra, Qiuyu J Huang, et al.
ACS Infectious Diseases
|
March 12, 2024
Contributions of Hyperactive Mutations in M<sup>pro</sup> from SARS-CoV-2 to Drug Resistance
Julia M Flynn, Sarah N Zvornicanin, Tenzin Tsepal, et al.
Mbio
|
April 4, 2025
Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50
Sarah N Zvornicanin, Ala M Shaqra, Julia Flynn, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Ophiobolin A Covalently Targets Complex IV Leading to Mitochondrial Metabolic Collapse in Cancer Cells
Flor A Gowans, Danny Q Thach, Yangzhi Wang, et al.
ACS Chemical Biology
|
May 13, 2024
Ophiobolin A Covalently Targets Mitochondrial Complex IV Leading to Metabolic Collapse in Cancer Cells
Flor A Gowans, Danny Q Thach, Zhouyang Zhu, et al.
Scientific Reports
|
December 12, 2023
Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon
Xiaolei Ma, Barbara Leon, Elizabeth Ornelas, et al.
ACS Infectious Diseases
|
June 30, 2023
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease
Julia M Flynn, Qiu Yu J Huang, Sarah N Zvornicanin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry
|
March 14, 2022
De novo Design of SARS-CoV-2 Main Protease Inhibitors
Christian Fischer, Nynke A Vepřek, Zisis Peitsinis, et al.
Cell
|
April 14, 2015
Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion
Oren S Rosenberg, Dustin Dovala, Xueming Li, et al.
Elife
|
June 20, 2022
Comprehensive fitness landscape of SARS-CoV-2 M<sup>pro</sup> reveals insights into viral resistance mechanisms
Julia M Flynn, Neha Samant, Gily Schneider-Nachum, et al.
Viruses
|
March 30, 2023
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses
Sarah N Zvornicanin, Ala M Shaqra, Qiuyu J Huang, et al.
ACS Infectious Diseases
|
March 12, 2024
Contributions of Hyperactive Mutations in M<sup>pro</sup> from SARS-CoV-2 to Drug Resistance
Julia M Flynn, Sarah N Zvornicanin, Tenzin Tsepal, et al.
Mbio
|
April 4, 2025
Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50
Sarah N Zvornicanin, Ala M Shaqra, Julia Flynn, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Ophiobolin A Covalently Targets Complex IV Leading to Mitochondrial Metabolic Collapse in Cancer Cells
Flor A Gowans, Danny Q Thach, Yangzhi Wang, et al.
ACS Chemical Biology
|
May 13, 2024
Ophiobolin A Covalently Targets Mitochondrial Complex IV Leading to Metabolic Collapse in Cancer Cells
Flor A Gowans, Danny Q Thach, Zhouyang Zhu, et al.
Scientific Reports
|
December 12, 2023
Structural and biophysical comparisons of the pomalidomide- and CC-220-induced interactions of SALL4 with cereblon
Xiaolei Ma, Barbara Leon, Elizabeth Ornelas, et al.
ACS Infectious Diseases
|
June 30, 2023
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease
Julia M Flynn, Qiu Yu J Huang, Sarah N Zvornicanin, et al.
Page
of 4